Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cumberland Pharmaceuticals is a specialty pharmaceutical company with a portfolio of FDA-approved branded prescription medicines targeting hospital acute care, gastroenterology, and oncology. Its commercial products include Acetadote (acetaminophen poisoning), Caldolor (pain/fever), Kristalose (constipation), Omeclamox-Pak (H. pylori infection), Sancuso (chemotherapy-induced nausea/vomiting), Vaprisol (hyponatremia), and Vibativ (serious bacterial infections). The pipeline includes ifetroban for rare diseases such as cardiomyopathy in Duchenne muscular dystrophy—recently granted orphan drug and rare pediatric disease designations—and other fibrotic conditions[4][2]. Recent clinical milestones include expanded labeling approvals and international launches.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cumberland Valley.